Optimind Pharma Corp. (CSE:OMND)

Optimind Pharma Balance Sheet

Financials in millions CAD. Fiscal year is March - February.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Cash & Equivalents	0.03	0.55	1.35
Cash & Short-Term Investments	0.03	0.55	1.35
Cash Growth	-94.80%	-59.16%	-
Accounts Receivable	0.02	0.03	-
Other Receivables	0.14	0.08	0
Receivables	0.16	0.12	0
Restricted Cash	-	-	0.51
Total Current Assets	0.19	0.67	1.86
Property, Plant & Equipment	-	0.09	0.12
Long-Term Investments	0.05	0.05	0.31
Goodwill	-	-	0.86
Other Intangible Assets	-	0.37	0.66
Total Assets	0.24	1.35	3.82
Accounts Payable	0.24	0.09	0.13
Short-Term Debt	0.13	0.5	-
Current Portion of Leases	-	0.03	0.02
Other Current Liabilities	-	-	0.51
Total Current Liabilities	0.37	0.62	0.66
Long-Term Leases	-	0.08	0.11
Long-Term Deferred Tax Liabilities	-	0.01	0
Total Liabilities	0.37	0.71	0.78
Common Stock	4.52	4.02	3.39
Additional Paid-In Capital	0.01	0.04	-
Retained Earnings	-4.82	-3.43	-0.35
Comprehensive Income & Other	0.16	-	-
Shareholders' Equity	-0.13	0.64	3.04
Total Liabilities & Equity	0.24	1.35	3.82
Total Debt	0.13	0.61	0.13
Net Cash (Debt)	-0.1	-0.06	1.22
Net Cash Per Share	-0.00	-0.00	0.03
Filing Date Shares Outstanding	116.89	97.93	43.59
Total Common Shares Outstanding	116.89	97.93	43.59
Working Capital	-0.18	0.04	1.2
Book Value Per Share	-0.00	0.01	0.07
Tangible Book Value	-0.13	0.27	1.52
Tangible Book Value Per Share	-0.00	0.00	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.